Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Randomized Placebo-Controlled Phase 2 Trial Evaluating Exemestane With or Without Enzalutamide in Patients With Hormone Receptor-Positive Breast CancerClin. Cancer Res 2020 Sep 28;[EPub Ahead of Print], I Krop, VG Abramson, M Colleoni, TA Traina, FA Holmes, L Garcia-Estevez, L Hart, A Awada, C Zamagni, PG Morris, LS Schwartzberg, SY Chan, A Gucalp, L Biganzoli, J Steinberg, L Sica, ME Trudeau, D Markova, JC Tarazi, Z Zhu, T O'Brien, C Kelly, EP Winer, D Yardley
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.